Free Trial

Tactile Systems Technology Q4 2023 Earnings Report

Tactile Systems Technology logo
$13.19 -0.44 (-3.23%)
As of 04:00 PM Eastern

Tactile Systems Technology EPS Results

Actual EPS
$0.38
Consensus EPS
$0.13
Beat/Miss
Beat by +$0.25
One Year Ago EPS
$0.29

Tactile Systems Technology Revenue Results

Actual Revenue
$77.65 million
Expected Revenue
$78.85 million
Beat/Miss
Missed by -$1.20 million
YoY Revenue Growth
N/A

Tactile Systems Technology Announcement Details

Quarter
Q4 2023
Time
Before Market Opens

Conference Call Resources

Remove Ads

Tactile Systems Technology Earnings Headlines

Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
A Closer Look At Tactile Systems Technology's Earnings
See More Tactile Systems Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tactile Systems Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tactile Systems Technology and other key companies, straight to your email.

About Tactile Systems Technology

Tactile Systems Technology (NASDAQ:TCMD), a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

View Tactile Systems Technology Profile

More Earnings Resources from MarketBeat